Trekking safety

Altitude sickness in Nepal: symptoms, prevention, and what to do

Several guides across this site tell readers to “discuss altitude symptoms with your guide” or plan for acclimatisation without ever explaining what that actually means. This page owns that gap: what acute mountain sickness (AMS) is, the ascent-rate rule that prevents most cases, how to recognise its two dangerous progressions, and what to actually do at each stage. It is a medical-explainer page, not personalised medical advice — nothing here replaces a travel-health professional, a doctor, or your guide’s judgement on the ground. This page stays scoped to altitude specifically — see Nepal travel health for vaccines, water safety, malaria, rabies, and general pre-trip health preparation. Last reviewed 12 August 2026 against current clinical-guideline and WebSearch-aggregated sources; see the sources section for what could and could not be independently fetched this run.

What AMS is, and why it happens

Air pressure drops as you gain elevation, which means each breath delivers less oxygen even though the air’s oxygen percentage stays the same — this is a physiological response to reduced air pressure, not simply a matter of the air being “thinner” in a way that scales with fitness. Acute mountain sickness is the body’s common, usually short-lived reaction to ascending faster than it can adjust: headache, nausea, fatigue, dizziness, and disturbed sleep, typically appearing within 6 to 12 hours of reaching a higher sleeping altitude above roughly 2,500 metres (Wilderness Medical Society). AMS on its own is common and usually resolves with rest and no further ascent — the risk is in ignoring it and continuing upward.

Prevention: the ascent-rate rule and “climb high, sleep low”

The single most effective prevention tool is pacing, not fitness or medication. The Wilderness Medical Society’s current clinical guideline recommends: avoid ascending directly to a sleeping altitude of 2,750 metres or higher in a single day from a lower starting point; once above 3,000 metres, do not increase your sleeping altitude by more than 500 metres per night; and add an extra acclimatisation night for roughly every 1,000 metres of sleeping-altitude gain (WMS 2024 guideline). The altitude you walk up to during the day matters less than the altitude you sleep at — the basis of the “climb high, sleep low” principle used across established Nepal trekking itineraries, where a rest day usually means a day hike to a higher point followed by a return to the same or a lower lodge for the night, not a day of complete inactivity.

Two supporting habits: stay well hydrated, since dehydration can mimic or worsen AMS symptoms and makes them harder to read accurately; and treat the ascent-rate guideline as a target to plan a route around, not a rule to break because a schedule is tight. If a trek’s itinerary compresses acclimatisation days to save time, that is a real trade-off, not a minor scheduling detail.

Fitness, age, and experience do not reliably protect you. Multiple independent medical and trekking-specific sources agree that susceptibility to altitude illness does not correlate reliably with fitness level, age, or prior high-altitude experience — ascent rate and individual physiology are the stronger predictors. Read alongside Nepal trekking for beginners on choosing a realistic route: a slower, better-paced itinerary is a more effective safeguard than training harder for a fast one.

Recognising AMS, HAPE, and HACE

AMS is the common starting point. HAPE (fluid in the lungs) and HACE (swelling in the brain) are its two dangerous progressions — both life-threatening, both treated the same way: immediate descent.

ConditionTypical onsetKey symptomsWhat to do
AMS (acute mountain sickness)6–12 hours after ascent above ~2,500mHeadache, nausea, fatigue, dizziness, poor sleepStop ascending, hydrate, treat symptoms, reassess before going higher
HAPE (high altitude pulmonary edema)Usually 2–5 days after ascentBreathlessness even at rest, a cough that worsens and can turn pink or frothy, chest tightness, falling exercise toleranceDescend immediately; treat as a medical emergency
HACE (high altitude cerebral edema)Usually 1–2 days after ascentSevere headache, confusion, loss of coordination (ataxia is the clinically distinctive sign), in severe cases loss of consciousnessDescend immediately; treat as a medical emergency

Sources: NCBI StatPearls, HAPE and NCBI StatPearls, HACE, cross-referenced against the WMS guideline and independent clinical summaries. HACE most often follows AMS that was not heeded, though it can occasionally appear without a clear AMS warning first — another reason not to treat a mild headache at altitude as background noise.

What to actually do, stage by stage

  • Mild AMS (headache, nausea, fatigue): stop ascending to a higher sleeping altitude, hydrate, treat symptoms (rest, over-the-counter pain relief as appropriate), and reassess the next morning before deciding whether to continue.
  • Worsening or moderate AMS: descend — even a few hundred metres of elevation loss commonly brings rapid improvement. Do not continue ascending while symptomatic.
  • Any sign of HAPE or HACE (breathlessness at rest, a worsening cough, confusion, loss of coordination): descend immediately, as far and as fast as can be done safely, and get to the nearest aid post, clinic, or evacuation point. These are medical emergencies, not conditions to wait out at altitude.

Descent is the primary treatment for all three conditions (WMS guideline); supplemental oxygen, if available, is a supportive measure alongside descent for HAPE and HACE, not a substitute for it.

Diamox (acetazolamide): what it is, and what it is not

This section explains what the medication does — it is not a prescription, a recommendation, or dosing instructions from NepalPick. Whether to take a preventive medication, and at what dose, is a decision to make with a travel-health professional or GP before departure, based on your own medical history and route.

Acetazolamide (brand name Diamox) is commonly cited in clinical references as a preventive medication for AMS, with 125 mg taken twice daily as the most commonly cited prophylactic dose, usually started 24–48 hours before ascent and continued for at least 48 hours at the highest altitude reached. A published clinical trial (the RADICAL trial) found a lower 62.5 mg twice-daily dose non-inferior to the standard dose for AMS prevention, but a separate later trial did not find the lower dose equally effective and reported an increased risk of AMS at that dose — the lower-dose research is genuinely mixed, not a settled alternative, so this page notes it exists without recommending either dose.

Reported common side effects include increased urination, tingling in the fingers, toes, or around the mouth, and an altered taste in carbonated drinks; it is a mild diuretic, so hydration matters more while taking it. It is generally avoided with impaired kidney function. On the sulfa-allergy question specifically: acetazolamide is a non-antibiotic sulfonamide, and the literature reports a low but non-zero cross-reactivity risk for people with a prior antibiotic-sulfa allergy — genuinely a “discuss with a doctor” question rather than a settled “safe” or “unsafe” answer. None of this is a substitute for your own doctor’s assessment; see Nepal packing list for why any altitude medication belongs in a pre-departure conversation, not a packing checklist decision.

Existing safety infrastructure on the ground

The Himalayan Rescue Association Nepal (HRA) runs seasonally staffed aid posts at Pheriche (Khumbu, on the Everest Base Camp route, roughly 4,250m) and Manang (Annapurna Circuit, roughly 3,550m), opening for the spring and autumn trekking seasons and focused specifically on assessing and treating AMS, HAPE, and HACE. HRA confirmed both posts open and staffed for the Spring 2026 season — a reasonable sign of continued operation, not a guarantee for whichever season you are trekking in; confirm current-season status with your guide or agency before relying on it. For what your travel insurance needs to cover, how helicopter rescue and claims actually work, and more on the HRA aid posts, see Nepal travel insurance — this page deliberately does not restate that page’s payment-model and claims detail.

Frequently asked questions

What is the first sign of altitude sickness?

Headache is the most commonly reported first symptom of acute mountain sickness (AMS), usually appearing 6 to 12 hours after arriving at a higher sleeping altitude, often alongside nausea, fatigue, dizziness, or poor sleep. A headache at altitude is not automatically AMS, but it is the standard cue to stop ascending, hydrate, and reassess rather than push on.

Can altitude sickness happen even if I'm fit?

Yes. Multiple independent medical and trekking-specific sources agree that susceptibility to altitude illness does not correlate reliably with age, fitness level, or prior high-altitude experience. Ascent rate and individual physiology matter more than how many kilometres you can run at sea level — a fit, experienced trekker can still develop AMS on a route that gains elevation too quickly.

Do I need Diamox for trekking in Nepal?

That depends on your route, your ascent profile, and your own medical history, which is a conversation to have with a travel-health professional or GP before departure, not something NepalPick can decide for you. Many treks with a gradual ascent profile and built-in acclimatisation days are completed without preventive medication; some travellers and some faster-paced or higher routes use it as a precaution. See the Diamox section below for what it does and does not do.

What's the difference between AMS, HAPE, and HACE?

AMS (acute mountain sickness) is the common, usually mild starting point — headache, nausea, fatigue, poor sleep. HAPE (high altitude pulmonary edema) is fluid in the lungs, signalled by breathlessness at rest and a worsening cough, typically appearing 2 to 5 days after ascent. HACE (high altitude cerebral edema) is swelling in the brain, signalled by confusion and loss of coordination (ataxia), typically appearing 1 to 2 days after ascent. Both HAPE and HACE are life-threatening medical emergencies that require immediate descent, not home management.

Official sources and what to reconfirm

Clinical facts on this page (symptom sets, ascent-rate guidance, treatment principle) are drawn from the Wilderness Medical Society’s current clinical practice guideline and NCBI/StatPearls, checked 12 August 2026. The Himalayan Rescue Association aid-post facts could not be independently re-fetched this run (WebFetch access to the site is currently blocked) and are cross-referenced via search aggregation instead — confirm current-season aid-post status directly with HRA or your trekking agency before relying on it. None of this page is personalised medical advice; consult a travel-health professional or doctor before your trip.